チロシンキナーゼ阻害剤市場2020：地域の見通し（アメリカ、ヨーロッパ、アジア太平洋、中東、アフリカ）別のサイズ、業界分析レポート、成長の可能性、価格動向、競争力のある市場シェア、市場統計と予測2020-2025 (アップデート版あり)

このレポートには、最新の市場図、統計、データが含まれています

ライセンスを選択

概要
目次

チロシンキナーゼ阻害剤は、細胞表面で利用可能なキナーゼ酵素の受容体部位に結合する小分子です。
世界のチロシンキナーゼ阻害剤市場は、世界中で高い有病率と癌の発生率の増加により拡大しています。
まとめグローバルチロシンキナーゼ阻害剤市場は、2015年から2019年までのCAGR xx％でxxx百万米ドルと評価されました。その後、2020年にはXXX百万米ドルに達し、2020年から2025年までのCAGRはxx％になります。

世界のチロシンキナーゼ阻害剤市場では、このレポートは特に北アメリカ、南アメリカ、ヨーロッパとアジア太平洋、および中東とアフリカに焦点を当てています。このレポートは、アプリケーション、タイプ、地域、および製造業者に基づいて市場を分類します。

メーカー別の市場細分化では、レポートは次の企業をカバーしています-
AstraZeneca
Pfizer
Novartis
Bristol-Myers Squibb
Bayer
Boehringer Ingelheim International
F. Hoffmann-La Roche
Johnson & Johnson
Eisai

地理的地域による市場細分化では、レポートは次の地域を分析しました-
北米（米国、カナダ、メキシコ）
ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
アジア太平洋（中国、日本、韓国、インド、東南アジア）
南アメリカ（ブラジル、アルゼンチン、コロンビアなど）
中東およびアフリカ（サウジアラビア、アラブ首長国連邦、エジプト、ナイジェリア、南アフリカ）

タイプによる市場細分化：
BCR-ABLチロシンキナーゼ阻害剤
上皮成長因子受容体（EGFR）チロシンキナーゼ阻害剤
血管内皮増殖因子（VEGFR）チロシンキナーゼ阻害剤
アプリケーションによる市場細分化：
慢性骨髄性白血病（CML）
肺癌
乳癌
腎細胞がん
他人
この調査は、次の重要な質問に対する回答を提供します。
• 2020年から2025年の予測期間におけるチロシンキナーゼ阻害剤市場の推定成長率と市場シェアおよび規模はどのくらいですか？
• 予測期間2020年から2025年のチロシンキナーゼ阻害剤市場の原動力は何ですか？
• 著名なマーケットプレーヤーは誰ですか？彼らは他の競合他社に対してどのように競争力を獲得しましたか？
• 世界中のチロシンキナーゼ阻害剤の業界の進歩に影響を与える市場動向は何ですか？
• 業界の進歩を制限する主な課題と脅威は何ですか？
• 市場は著名な市場プレーヤーにとってどのような機会を持っていますか？
このレポートに関する特別な要件がある場合は、お知らせください。カスタムレポートを提供できます。

注–より正確な市場予測を提供するために、COVID-19の影響を考慮して、すべてのレポートが配信前に更新されます。

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Tyrosine Kinase Inhibitors Market Size Growth Rate by Type (2020-2025)
1.3.2 BCR-ABL Tyrosine Kinase Inhibitor
1.3.3 Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
1.3.4 Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
1.4 Market Segment by Application
1.4.1 Global Tyrosine Kinase Inhibitors Market Share by Application (2020-2025)
1.4.2 Chronic Myeloid Leukemia (CML)
1.4.3 Lung Cancer
1.4.4 Breast Cancer
1.4.5 Renal Cell Cancer
1.4.6 Others
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Tyrosine Kinase Inhibitors Market Size
2.1.1 Global Tyrosine Kinase Inhibitors Revenue 2015-2025
2.1.2 Global Tyrosine Kinase Inhibitors Sales 2015-2025
2.2 Tyrosine Kinase Inhibitors Growth Rate by Regions
2.2.1 Global Tyrosine Kinase Inhibitors Sales by Regions 2015-2019
2.2.2 Global Tyrosine Kinase Inhibitors Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Tyrosine Kinase Inhibitors Sales by Manufacturers
3.1.1 Tyrosine Kinase Inhibitors Sales by Manufacturers 2015-2019
3.1.2 Tyrosine Kinase Inhibitors Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Tyrosine Kinase Inhibitors Revenue by Manufacturers (2015-2019)
3.2.2 Tyrosine Kinase Inhibitors Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Tyrosine Kinase Inhibitors Market Concentration Ratio (CR5 and HHI)
3.3 Tyrosine Kinase Inhibitors Price by Manufacturers
3.4 Key Manufacturers Tyrosine Kinase Inhibitors Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Tyrosine Kinase Inhibitors Market
3.6 Key Manufacturers Tyrosine Kinase Inhibitors Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 BCR-ABL Tyrosine Kinase Inhibitor Sales and Revenue (2015-2019)
4.1.2 Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Sales and Revenue (2015-2019)
4.1.3 Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors Sales and Revenue (2015-2019)
4.2 Global Tyrosine Kinase Inhibitors Sales Market Share by Type
4.3 Global Tyrosine Kinase Inhibitors Revenue Market Share by Type
4.4 Tyrosine Kinase Inhibitors Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Tyrosine Kinase Inhibitors Sales by Application

6 United States
6.1 United States Tyrosine Kinase Inhibitors Breakdown Data by Company
6.2 United States Tyrosine Kinase Inhibitors Breakdown Data by Type
6.3 United States Tyrosine Kinase Inhibitors Breakdown Data by Application

7 European Union
7.1 European Union Tyrosine Kinase Inhibitors Breakdown Data by Company
7.2 European Union Tyrosine Kinase Inhibitors Breakdown Data by Type
7.3 European Union Tyrosine Kinase Inhibitors Breakdown Data by Application

8 China
8.1 China Tyrosine Kinase Inhibitors Breakdown Data by Company
8.2 China Tyrosine Kinase Inhibitors Breakdown Data by Type
8.3 China Tyrosine Kinase Inhibitors Breakdown Data by Application

9 Rest of World
9.1 Rest of World Tyrosine Kinase Inhibitors Breakdown Data by Company
9.2 Rest of World Tyrosine Kinase Inhibitors Breakdown Data by Type
9.3 Rest of World Tyrosine Kinase Inhibitors Breakdown Data by Application
9.4 Rest of World Tyrosine Kinase Inhibitors Breakdown Data by Countries
9.4.1 Rest of World Tyrosine Kinase Inhibitors Sales by Countries
9.4.2 Rest of World Tyrosine Kinase Inhibitors Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia

10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Tyrosine Kinase Inhibitors
10.1.4 Tyrosine Kinase Inhibitors Product Introduction
10.1.5 AstraZeneca Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Tyrosine Kinase Inhibitors
10.2.4 Tyrosine Kinase Inhibitors Product Introduction
10.2.5 Pfizer Recent Development
10.3 Novartis
10.3.1 Novartis Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Tyrosine Kinase Inhibitors
10.3.4 Tyrosine Kinase Inhibitors Product Introduction
10.3.5 Novartis Recent Development
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Tyrosine Kinase Inhibitors
10.4.4 Tyrosine Kinase Inhibitors Product Introduction
10.4.5 Bristol-Myers Squibb Recent Development
10.5 Bayer
10.5.1 Bayer Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Tyrosine Kinase Inhibitors
10.5.4 Tyrosine Kinase Inhibitors Product Introduction
10.5.5 Bayer Recent Development
10.6 Boehringer Ingelheim International
10.6.1 Boehringer Ingelheim International Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Tyrosine Kinase Inhibitors
10.6.4 Tyrosine Kinase Inhibitors Product Introduction
10.6.5 Boehringer Ingelheim International Recent Development
10.7 F. Hoffmann-La Roche
10.7.1 F. Hoffmann-La Roche Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Tyrosine Kinase Inhibitors
10.7.4 Tyrosine Kinase Inhibitors Product Introduction
10.7.5 F. Hoffmann-La Roche Recent Development
10.8 Johnson & Johnson
10.8.1 Johnson & Johnson Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Tyrosine Kinase Inhibitors
10.8.4 Tyrosine Kinase Inhibitors Product Introduction
10.8.5 Johnson & Johnson Recent Development
10.9 Eisai
10.9.1 Eisai Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Tyrosine Kinase Inhibitors
10.9.4 Tyrosine Kinase Inhibitors Product Introduction
10.9.5 Eisai Recent Development

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Tyrosine Kinase Inhibitors Sales Channels
11.2.2 Tyrosine Kinase Inhibitors Distributors
11.3 Tyrosine Kinase Inhibitors Customers

12 Market Forecast
12.1 Global Tyrosine Kinase Inhibitors Sales and Revenue Forecast 2020-2025
12.2 Global Tyrosine Kinase Inhibitors Sales Forecast by Type
12.3 Global Tyrosine Kinase Inhibitors Sales Forecast by Application
12.4 Tyrosine Kinase Inhibitors Forecast by Regions
12.4.1 Global Tyrosine Kinase Inhibitors Sales Forecast by Regions 2020-2025
12.4.2 Global Tyrosine Kinase Inhibitors Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer